Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)

Japan · Delayed Price · Currency is JPY

6,036.00

-22.00 (-0.36%)

Mar 5, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is March - February.

Millions JPY. Fiscal year is Mar - Feb.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	Feb '19 Feb 28, 2019	Feb '18 Feb 28, 2018	Feb '17 Feb 28, 2017	Feb '16 Feb 29, 2016
Pharmaceuticals Business	-	138.46B	125.20B	117.29B	111.76B
Pharmaceuticals Business Growth	-	10.59%	6.74%	4.95%	-19.22%
Others	3.35B	3.25B	3.13B	2.90B	2.75B
Others Growth	3.11%	3.97%	7.79%	5.53%	4.13%
Medicine and Related Product Business	152.65B	-	-	-	-
Total	156.01B	141.71B	128.33B	120.19B	114.51B
Total Growth	10.09%	10.42%	6.77%	4.96%	-18.78%

Revenue by Geography

Financials in millions JPY. Fiscal year is March - February.

Millions JPY. Fiscal year is Mar - Feb.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	Feb '19 Feb 28, 2019	Feb '18 Feb 28, 2018	Feb '17 Feb 28, 2017	Feb '16 Feb 29, 2016
Japan	82.36B	81.03B	74.64B	78.73B	75.17B
Japan Growth	1.65%	8.56%	-5.20%	4.74%	-22.83%
United States of America	38.90B	31.04B	28.30B	22.11B	22.26B
United States of America Growth	25.32%	9.69%	28.00%	-0.68%	-8.65%
Others	34.75B	29.64B	25.40B	19.36B	17.08B
Others Growth	17.22%	16.71%	31.20%	13.32%	-11.13%
Total	156.01B	141.71B	128.33B	120.19B	114.51B
Total Growth	10.09%	10.42%	6.77%	4.96%	-18.78%

Source: S&P Global Market Intelligence.